These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 12189526

  • 1. Construction and production of oncotropic vectors, derived from MVM(p), that share reduced sequence homology with helper plasmids.
    Clément N, Velu T, Brandenburger A.
    Cancer Gene Ther; 2002 Sep; 9(9):762-70. PubMed ID: 12189526
    [Abstract] [Full Text] [Related]

  • 2. Cloning and sequencing of defective particles derived from the autonomous parvovirus minute virus of mice for the construction of vectors with minimal cis-acting sequences.
    Clément N, Avalosse B, El Bakkouri K, Velu T, Brandenburger A.
    J Virol; 2001 Feb; 75(3):1284-93. PubMed ID: 11152501
    [Abstract] [Full Text] [Related]

  • 3. Autonomous parvovirus vectors: preventing the generation of wild-type or replication-competent virus.
    Brandenburger A, Velu T.
    J Gene Med; 2004 Feb; 6 Suppl 1():S203-11. PubMed ID: 14978763
    [Abstract] [Full Text] [Related]

  • 4. A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination.
    Dupont F, Karim A, Dumon JC, Mine N, Avalosse B.
    Gene Ther; 2001 Jun; 8(12):921-9. PubMed ID: 11426332
    [Abstract] [Full Text] [Related]

  • 5. A novel packaging system for the generation of helper-free oncolytic MVM vector stocks.
    Brandenburger A, Russell S.
    Gene Ther; 1996 Oct; 3(10):927-31. PubMed ID: 8908507
    [Abstract] [Full Text] [Related]

  • 6. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
    Pechan PA, Herrlinger U, Aghi M, Jacobs A, Breakefield XO.
    J Gene Med; 1999 Oct; 1(3):176-85. PubMed ID: 10738566
    [Abstract] [Full Text] [Related]

  • 7. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
    Saeki Y, Fraefel C, Ichikawa T, Breakefield XO, Chiocca EA.
    Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
    [Abstract] [Full Text] [Related]

  • 8. Encapsidation of a recombinant LuIII parvovirus genome by H1 virus and the fibrotropic or lymphotropic strains of minute virus of mice.
    Maxwell IH, Long CJ, Carlson JO, Rhode SL, Maxwell F.
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1175-9. PubMed ID: 8509766
    [Abstract] [Full Text] [Related]

  • 9. The infectivity and lytic activity of minute virus of mice wild-type and derived vector particles are strikingly different.
    Lang SI, Boelz S, Stroh-Dege AY, Rommelaere J, Dinsart C, Cornelis JJ.
    J Virol; 2005 Jan; 79(1):289-98. PubMed ID: 15596824
    [Abstract] [Full Text] [Related]

  • 10. Virofection: a one-step procedure for using replication-defective retrovirus vectors.
    Flamant F, Samarut J.
    Virology; 1995 Aug 01; 211(1):234-40. PubMed ID: 7645216
    [Abstract] [Full Text] [Related]

  • 11. Sequence motifs in the replicator protein of parvovirus MVM essential for nicking and covalent attachment to the viral origin: identification of the linking tyrosine.
    Nüesch JP, Cotmore SF, Tattersall P.
    Virology; 1995 May 10; 209(1):122-35. PubMed ID: 7747462
    [Abstract] [Full Text] [Related]

  • 12. Recombination within the nonstructural genes of the parvovirus minute virus of mice (MVM) generates functional levels of wild-type NS1, which can be detected in the absence of selective pressure following transfection of nonreplicating plasmids.
    Pearson JL, Pintel DJ.
    Virology; 2000 Mar 30; 269(1):128-36. PubMed ID: 10725205
    [Abstract] [Full Text] [Related]

  • 13. Production of recombinant H1 parvovirus stocks devoid of replication-competent viruses.
    Brown CS, DiSumma FM, Rommelaere J, Dege AY, Cornelis JJ, Dinsart C, Spaan WJ.
    Hum Gene Ther; 2002 Dec 10; 13(18):2135-45. PubMed ID: 12542845
    [Abstract] [Full Text] [Related]

  • 14. Replication of minute virus of mice minigenomes: novel replication elements required for MVM DNA replication.
    Tam P, Astell CR.
    Virology; 1993 Apr 10; 193(2):812-24. PubMed ID: 8460487
    [Abstract] [Full Text] [Related]

  • 15. The left-end and right-end origins of minute virus of mice DNA differ in their capacity to direct episomal amplification and integration in vivo.
    Corsini J, Cotmore SF, Tattersall P, Winocour E.
    Virology; 2001 Sep 15; 288(1):154-63. PubMed ID: 11543668
    [Abstract] [Full Text] [Related]

  • 16. Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production.
    Li C, Samulski RJ.
    Virology; 2005 Apr 25; 335(1):10-21. PubMed ID: 15823602
    [Abstract] [Full Text] [Related]

  • 17. Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapy.
    Chakraborty AK, Zink MA, Hodgson CP.
    Cancer Gene Ther; 1994 Jun 25; 1(2):113-8. PubMed ID: 7621242
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Genetic design of an optimized packaging cell line for gene vectors transducing human B cells.
    Hettich E, Janz A, Zeidler R, Pich D, Hellebrand E, Weissflog B, Moosmann A, Hammerschmidt W.
    Gene Ther; 2006 May 25; 13(10):844-56. PubMed ID: 16421600
    [Abstract] [Full Text] [Related]

  • 20. Generation of replication-defective helper-free vectors based on simian immunodeficiency virus.
    Kim SS, Kothari N, You XJ, Robinson WE, Schnell T, Uberla K, Fan H.
    Virology; 2001 Mar 30; 282(1):154-67. PubMed ID: 11259198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.